🇺🇸 FDA
Patent

US 10183917

Tricyclic compounds and uses thereof in medicine

granted A61KA61K31/42A61K31/4353

Quick answer

US patent 10183917 (Tricyclic compounds and uses thereof in medicine) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/42, A61K31/4353, A61K31/4985, A61K31/519